ELIXIRGEN THERAPEUTICS
Live / Applied — Third extension granted (statement of use) (as of 19 Aug 2025)
What this means for you
Not registered yet, but its 01 Dec 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97978846
- Mark type
- Design + words
- Filed
- 01 Dec 2021
- Published for opposition
- 09 Jan 2024
- Attorney of record
- Leonard D. Bowersox
Goods and services
- Class 035 — Advertising and business services: Retail store services featuring pharmaceutical drugs and chemical preparations; retail store services featuring pharmaceutical drugs and chemical preparations for cell and gene therapy
Owner
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
- Elixirgen Therapeutics, Inc., Baltimore, MD, US
Prosecution history
- 19 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2025 — SOU EXTENSION 3 GRANTED
- 13 Aug 2025 — SOU EXTENSION 3 FILED
- 14 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2025 — SOU EXTENSION 2 GRANTED
- 12 Feb 2025 — SOU EXTENSION 2 FILED
- 12 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2024 — SOU EXTENSION 1 GRANTED
- 04 Sept 2024 — SOU EXTENSION 1 FILED
- 04 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Sept 2024 — DIVISIONAL PROCESSING COMPLETE
- 22 Mar 2024 — DIVISIONAL REQUEST RECEIVED
- 04 Sept 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL